Table of Content

1 Human VEGF Antibody Market Overview
1.1 Product Overview and Scope of Human VEGF Antibody
1.2 Human VEGF Antibody Segment by Type
1.2.1 Global Human VEGF Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rabbit
1.2.3 Mouse
1.2.4 Goat
1.2.5 Others
1.3 Human VEGF Antibody Segment by Application
1.3.1 Human VEGF Antibody Sales Comparison by Application: (2021-2027)
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Human VEGF Antibody Market Size Estimates and Forecasts
1.4.1 Global Human VEGF Antibody Revenue 2016-2027
1.4.2 Global Human VEGF Antibody Sales 2016-2027
1.4.3 Human VEGF Antibody Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human VEGF Antibody Market Competition by Manufacturers
2.1 Global Human VEGF Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human VEGF Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human VEGF Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human VEGF Antibody Manufacturing Sites, Area Served, Product Type
2.5 Human VEGF Antibody Market Competitive Situation and Trends
2.5.1 Human VEGF Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human VEGF Antibody Players Market Share by Revenue
2.5.3 Global Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human VEGF Antibody Retrospective Market Scenario by Region
3.1 Global Human VEGF Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Human VEGF Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Human VEGF Antibody Market Facts & Figures by Country
3.3.1 North America Human VEGF Antibody Sales by Country
3.3.2 North America Human VEGF Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human VEGF Antibody Market Facts & Figures by Country
3.4.1 Europe Human VEGF Antibody Sales by Country
3.4.2 Europe Human VEGF Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human VEGF Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Human VEGF Antibody Sales by Region
3.5.2 Asia Pacific Human VEGF Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human VEGF Antibody Market Facts & Figures by Country
3.6.1 Latin America Human VEGF Antibody Sales by Country
3.6.2 Latin America Human VEGF Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human VEGF Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Human VEGF Antibody Sales by Country
3.7.2 Middle East and Africa Human VEGF Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Human VEGF Antibody Historic Market Analysis by Type
4.1 Global Human VEGF Antibody Sales Market Share by Type (2016-2021)
4.2 Global Human VEGF Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Human VEGF Antibody Price by Type (2016-2021)

5 Global Human VEGF Antibody Historic Market Analysis by Application
5.1 Global Human VEGF Antibody Sales Market Share by Application (2016-2021)
5.2 Global Human VEGF Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Human VEGF Antibody Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Thermo Fisher Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 MilliporeSigma
6.2.1 MilliporeSigma Corporation Information
6.2.2 MilliporeSigma Description and Business Overview
6.2.3 MilliporeSigma Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 MilliporeSigma Product Portfolio
6.2.5 MilliporeSigma Recent Developments/Updates
6.3 Santa Cruz Biotechnology
6.3.1 Santa Cruz Biotechnology Corporation Information
6.3.2 Santa Cruz Biotechnology Description and Business Overview
6.3.3 Santa Cruz Biotechnology Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Santa Cruz Biotechnology Product Portfolio
6.3.5 Santa Cruz Biotechnology Recent Developments/Updates
6.4 Abcam
6.4.1 Abcam Corporation Information
6.4.2 Abcam Description and Business Overview
6.4.3 Abcam Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abcam Product Portfolio
6.4.5 Abcam Recent Developments/Updates
6.5 R&D Systems
6.5.1 R&D Systems Corporation Information
6.5.2 R&D Systems Description and Business Overview
6.5.3 R&D Systems Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.5.4 R&D Systems Product Portfolio
6.5.5 R&D Systems Recent Developments/Updates
6.6 Novus Biologicals
6.6.1 Novus Biologicals Corporation Information
6.6.2 Novus Biologicals Description and Business Overview
6.6.3 Novus Biologicals Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novus Biologicals Product Portfolio
6.6.5 Novus Biologicals Recent Developments/Updates
6.7 Abnova
6.6.1 Abnova Corporation Information
6.6.2 Abnova Description and Business Overview
6.6.3 Abnova Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abnova Product Portfolio
6.7.5 Abnova Recent Developments/Updates
6.8 ImmunoStar
6.8.1 ImmunoStar Corporation Information
6.8.2 ImmunoStar Description and Business Overview
6.8.3 ImmunoStar Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.8.4 ImmunoStar Product Portfolio
6.8.5 ImmunoStar Recent Developments/Updates
6.9 OriGene
6.9.1 OriGene Corporation Information
6.9.2 OriGene Description and Business Overview
6.9.3 OriGene Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.9.4 OriGene Product Portfolio
6.9.5 OriGene Recent Developments/Updates
6.10 LifeSpan Biosciences
6.10.1 LifeSpan Biosciences Corporation Information
6.10.2 LifeSpan Biosciences Description and Business Overview
6.10.3 LifeSpan Biosciences Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LifeSpan Biosciences Product Portfolio
6.10.5 LifeSpan Biosciences Recent Developments/Updates
6.11 Sino Biological
6.11.1 Sino Biological Corporation Information
6.11.2 Sino Biological Human VEGF Antibody Description and Business Overview
6.11.3 Sino Biological Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sino Biological Product Portfolio
6.11.5 Sino Biological Recent Developments/Updates
6.12 Bio-Rad
6.12.1 Bio-Rad Corporation Information
6.12.2 Bio-Rad Human VEGF Antibody Description and Business Overview
6.12.3 Bio-Rad Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Bio-Rad Product Portfolio
6.12.5 Bio-Rad Recent Developments/Updates
6.13 BioLegend
6.13.1 BioLegend Corporation Information
6.13.2 BioLegend Human VEGF Antibody Description and Business Overview
6.13.3 BioLegend Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.13.4 BioLegend Product Portfolio
6.13.5 BioLegend Recent Developments/Updates
6.14 Rockland Immunochemicals
6.14.1 Rockland Immunochemicals Corporation Information
6.14.2 Rockland Immunochemicals Human VEGF Antibody Description and Business Overview
6.14.3 Rockland Immunochemicals Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Rockland Immunochemicals Product Portfolio
6.14.5 Rockland Immunochemicals Recent Developments/Updates
6.15 Agrisera
6.15.1 Agrisera Corporation Information
6.15.2 Agrisera Human VEGF Antibody Description and Business Overview
6.15.3 Agrisera Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Agrisera Product Portfolio
6.15.5 Agrisera Recent Developments/Updates
6.16 Boster
6.16.1 Boster Corporation Information
6.16.2 Boster Human VEGF Antibody Description and Business Overview
6.16.3 Boster Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Boster Product Portfolio
6.16.5 Boster Recent Developments/Updates
6.17 ProMab
6.17.1 ProMab Corporation Information
6.17.2 ProMab Human VEGF Antibody Description and Business Overview
6.17.3 ProMab Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.17.4 ProMab Product Portfolio
6.17.5 ProMab Recent Developments/Updates
6.18 Creative Biomart
6.18.1 Creative Biomart Corporation Information
6.18.2 Creative Biomart Human VEGF Antibody Description and Business Overview
6.18.3 Creative Biomart Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Creative Biomart Product Portfolio
6.18.5 Creative Biomart Recent Developments/Updates
6.19 Enzo Life Sciences
6.19.1 Enzo Life Sciences Corporation Information
6.19.2 Enzo Life Sciences Human VEGF Antibody Description and Business Overview
6.19.3 Enzo Life Sciences Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Enzo Life Sciences Product Portfolio
6.19.5 Enzo Life Sciences Recent Developments/Updates
6.20 Bon Opus Biosciences
6.20.1 Bon Opus Biosciences Corporation Information
6.20.2 Bon Opus Biosciences Human VEGF Antibody Description and Business Overview
6.20.3 Bon Opus Biosciences Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Bon Opus Biosciences Product Portfolio
6.20.5 Bon Opus Biosciences Recent Developments/Updates
6.21 Absolute Antibody
6.21.1 Absolute Antibody Corporation Information
6.21.2 Absolute Antibody Human VEGF Antibody Description and Business Overview
6.21.3 Absolute Antibody Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Absolute Antibody Product Portfolio
6.21.5 Absolute Antibody Recent Developments/Updates
6.22 US Biological
6.22.1 US Biological Corporation Information
6.22.2 US Biological Human VEGF Antibody Description and Business Overview
6.22.3 US Biological Human VEGF Antibody Sales, Revenue and Gross Margin (2016-2021)
6.22.4 US Biological Product Portfolio
6.22.5 US Biological Recent Developments/Updates

7 Human VEGF Antibody Manufacturing Cost Analysis
7.1 Human VEGF Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human VEGF Antibody
7.4 Human VEGF Antibody Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human VEGF Antibody Distributors List
8.3 Human VEGF Antibody Customers

9 Human VEGF Antibody Market Dynamics
9.1 Human VEGF Antibody Industry Trends
9.2 Human VEGF Antibody Growth Drivers
9.3 Human VEGF Antibody Market Challenges
9.4 Human VEGF Antibody Market Restraints

10 Global Market Forecast
10.1 Human VEGF Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human VEGF Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human VEGF Antibody by Type (2022-2027)
10.2 Human VEGF Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human VEGF Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human VEGF Antibody by Application (2022-2027)
10.3 Human VEGF Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human VEGF Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human VEGF Antibody by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human VEGF Antibody Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Human VEGF Antibody Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Human VEGF Antibody Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Human VEGF Antibody Covered in This Study
Table 5. Global Human VEGF Antibody Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Human VEGF Antibody Sales Share by Manufacturers (2016-2021)
Table 7. Global Human VEGF Antibody Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human VEGF Antibody Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human VEGF Antibody Average Price (USD/g) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human VEGF Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Human VEGF Antibody Product Type
Table 12. Global Human VEGF Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human VEGF Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human VEGF Antibody as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human VEGF Antibody Sales by Region (2016-2021) & (Kg)
Table 16. Global Human VEGF Antibody Sales Market Share by Region (2016-2021)
Table 17. Global Human VEGF Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human VEGF Antibody Sales by Country (2016-2021) & (Kg)
Table 19. North America Human VEGF Antibody Sales Market Share by Country (2016-2021)
Table 20. North America Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human VEGF Antibody Revenue Market Share by Country (2016-2021)
Table 22. Europe Human VEGF Antibody Sales by Country (2016-2021) & (Kg)
Table 23. Europe Human VEGF Antibody Sales Market Share by Country (2016-2021)
Table 24. Europe Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human VEGF Antibody Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human VEGF Antibody Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Human VEGF Antibody Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human VEGF Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human VEGF Antibody Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human VEGF Antibody Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Human VEGF Antibody Sales Market Share by Country (2016-2021)
Table 32. Latin America Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human VEGF Antibody Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human VEGF Antibody Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Human VEGF Antibody Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human VEGF Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human VEGF Antibody Revenue Market Share by Country (2016-2021)
Table 38. Global Human VEGF Antibody Sales (Kg) by Type (2016-2021)
Table 39. Global Human VEGF Antibody Sales Market Share by Type (2016-2021)
Table 40. Global Human VEGF Antibody Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human VEGF Antibody Revenue Share by Type (2016-2021)
Table 42. Global Human VEGF Antibody Price (USD/g) by Type (2016-2021)
Table 43. Global Human VEGF Antibody Sales (Kg) by Application (2016-2021)
Table 44. Global Human VEGF Antibody Sales Market Share by Application (2016-2021)
Table 45. Global Human VEGF Antibody Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human VEGF Antibody Revenue Share by Application (2016-2021)
Table 47. Global Human VEGF Antibody Price (USD/g) by Application (2016-2021)
Table 48. Thermo Fisher Corporation Information
Table 49. Thermo Fisher Description and Business Overview
Table 50. Thermo Fisher Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 51. Thermo Fisher Human VEGF Antibody Product
Table 52. Thermo Fisher Recent Developments/Updates
Table 53. MilliporeSigma Corporation Information
Table 54. MilliporeSigma Description and Business Overview
Table 55. MilliporeSigma Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 56. MilliporeSigma Human VEGF Antibody Product
Table 57. MilliporeSigma Recent Developments/Updates
Table 58. Santa Cruz Biotechnology Corporation Information
Table 59. Santa Cruz Biotechnology Description and Business Overview
Table 60. Santa Cruz Biotechnology Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 61. Santa Cruz Biotechnology Human VEGF Antibody Product
Table 62. Santa Cruz Biotechnology Recent Developments/Updates
Table 63. Abcam Corporation Information
Table 64. Abcam Description and Business Overview
Table 65. Abcam Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 66. Abcam Human VEGF Antibody Product
Table 67. Abcam Recent Developments/Updates
Table 68. R&D Systems Corporation Information
Table 69. R&D Systems Description and Business Overview
Table 70. R&D Systems Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 71. R&D Systems Human VEGF Antibody Product
Table 72. R&D Systems Recent Developments/Updates
Table 73. Novus Biologicals Corporation Information
Table 74. Novus Biologicals Description and Business Overview
Table 75. Novus Biologicals Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 76. Novus Biologicals Human VEGF Antibody Product
Table 77. Novus Biologicals Recent Developments/Updates
Table 78. Abnova Corporation Information
Table 79. Abnova Description and Business Overview
Table 80. Abnova Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 81. Abnova Human VEGF Antibody Product
Table 82. Abnova Recent Developments/Updates
Table 83. ImmunoStar Corporation Information
Table 84. ImmunoStar Description and Business Overview
Table 85. ImmunoStar Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 86. ImmunoStar Human VEGF Antibody Product
Table 87. ImmunoStar Recent Developments/Updates
Table 88. OriGene Corporation Information
Table 89. OriGene Description and Business Overview
Table 90. OriGene Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 91. OriGene Human VEGF Antibody Product
Table 92. OriGene Recent Developments/Updates
Table 93. LifeSpan Biosciences Corporation Information
Table 94. LifeSpan Biosciences Description and Business Overview
Table 95. LifeSpan Biosciences Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 96. LifeSpan Biosciences Human VEGF Antibody Product
Table 97. LifeSpan Biosciences Recent Developments/Updates
Table 98. Sino Biological Corporation Information
Table 99. Sino Biological Description and Business Overview
Table 100. Sino Biological Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 101. Sino Biological Human VEGF Antibody Product
Table 102. Sino Biological Recent Developments/Updates
Table 103. Bio-Rad Corporation Information
Table 104. Bio-Rad Description and Business Overview
Table 105. Bio-Rad Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 106. Bio-Rad Human VEGF Antibody Product
Table 107. Bio-Rad Recent Developments/Updates
Table 108. BioLegend Corporation Information
Table 109. BioLegend Description and Business Overview
Table 110. BioLegend Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 111. BioLegend Human VEGF Antibody Product
Table 112. BioLegend Recent Developments/Updates
Table 113. Rockland Immunochemicals Corporation Information
Table 114. Rockland Immunochemicals Description and Business Overview
Table 115. Rockland Immunochemicals Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 116. Rockland Immunochemicals Human VEGF Antibody Product
Table 117. Rockland Immunochemicals Recent Developments/Updates
Table 118. Agrisera Corporation Information
Table 119. Agrisera Description and Business Overview
Table 120. Agrisera Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 121. Agrisera Human VEGF Antibody Product
Table 122. Agrisera Recent Developments/Updates
Table 123. Boster Corporation Information
Table 124. Boster Description and Business Overview
Table 125. Boster Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 126. Boster Human VEGF Antibody Product
Table 127. Boster Recent Developments/Updates
Table 128. ProMab Corporation Information
Table 129. ProMab Description and Business Overview
Table 130. ProMab Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 131. ProMab Human VEGF Antibody Product
Table 132. ProMab Recent Developments/Updates
Table 133. Creative Biomart Corporation Information
Table 134. Creative Biomart Description and Business Overview
Table 135. Creative Biomart Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 136. Creative Biomart Human VEGF Antibody Product
Table 137. Creative Biomart Recent Developments/Updates
Table 138. Enzo Life Sciences Corporation Information
Table 139. Enzo Life Sciences Description and Business Overview
Table 140. Enzo Life Sciences Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 141. Enzo Life Sciences Human VEGF Antibody Product
Table 142. Enzo Life Sciences Recent Developments/Updates
Table 143. Bon Opus Biosciences Corporation Information
Table 144. Bon Opus Biosciences Description and Business Overview
Table 145. Bon Opus Biosciences Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 146. Bon Opus Biosciences Human VEGF Antibody Product
Table 147. Bon Opus Biosciences Recent Developments/Updates
Table 148. Absolute Antibody Corporation Information
Table 149. Absolute Antibody Description and Business Overview
Table 150. Absolute Antibody Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 151. Absolute Antibody Human VEGF Antibody Product
Table 152. Absolute Antibody Recent Developments/Updates
Table 153. US Biological Corporation Information
Table 154. US Biological Description and Business Overview
Table 155. US Biological Human VEGF Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021)
Table 156. US Biological Human VEGF Antibody Product
Table 157. US Biological Recent Developments/Updates
Table 158. Production Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Human VEGF Antibody Distributors List
Table 161. Human VEGF Antibody Customers List
Table 162. Human VEGF Antibody Market Trends
Table 163. Human VEGF Antibody Growth Drivers
Table 164. Human VEGF Antibody Market Restraints
Table 165. Global Human VEGF Antibody Sales Forecast by Type (2022-2027) & (Kg)
Table 166. Global Human VEGF Antibody Sales Market Share Forecast by Type (2022-2027)
Table 167. Global Human VEGF Antibody Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 168. Global Human VEGF Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 169. Global Human VEGF Antibody Sales Forecast by Application (2022-2027) & (Kg)
Table 170. Global Human VEGF Antibody Sales Market Share Forecast by Application (2022-2027)
Table 171. Global Human VEGF Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 172. Global Human VEGF Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 173. Global Human VEGF Antibody Sales Forecast by Region (2022-2027) & (Kg)
Table 174. Global Human VEGF Antibody Sales Market Share Forecast by Region (2022-2027)
Table 175. Global Human VEGF Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 176. Global Human VEGF Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human VEGF Antibody
Figure 2. Global Human VEGF Antibody Market Share by Type in 2020 & 2027
Figure 3. Rabbit Product Picture
Figure 4. Mouse Product Picture
Figure 5. Goat Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human VEGF Antibody Market Share by Application in 2020 & 2027
Figure 8. Laboratory
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Human VEGF Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human VEGF Antibody Market Size 2016-2027 (US$ Million)
Figure 13. Global Human VEGF Antibody Sales 2016-2027 (Kg)
Figure 14. Global Human VEGF Antibody Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Human VEGF Antibody Sales Share by Manufacturers in 2020
Figure 16. Global Human VEGF Antibody Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Human VEGF Antibody Players: Market Share by Revenue in 2020
Figure 18. Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Human VEGF Antibody Sales Market Share by Region (2016-2021)
Figure 20. Global Human VEGF Antibody Sales Market Share by Region in 2020
Figure 21. Global Human VEGF Antibody Revenue Market Share by Region (2016-2021)
Figure 22. Global Human VEGF Antibody Revenue Market Share by Region in 2020
Figure 23. U.S. Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Human VEGF Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Human VEGF Antibody by Type (2016-2021)
Figure 48. Sales Market Share of Human VEGF Antibody by Application (2016-2021)
Figure 49. Sales Market Share of Human VEGF Antibody by Application in 2020
Figure 50. Revenue Share of Human VEGF Antibody by Application (2016-2021)
Figure 51. Revenue Share of Human VEGF Antibody by Application in 2020
Figure 52. Manufacturing Cost Structure of Human VEGF Antibody
Figure 53. Manufacturing Process Analysis of Human VEGF Antibody
Figure 54. Human VEGF Antibody Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed